Empresas y finanzas

Covidien Introduces Sandman Intro(TM) CPAP Device



    Covidien Ltd. (NYSE: COV, BSX: COV), a leading supplier of
    continuous positive airway pressure (CPAP) and other sleep therapy
    devices and accessories, announced today the introduction of an
    all-new CPAP device with a fully-integrated heated humidifier. The
    product is available throughout the United States and Europe and will
    be phased into other global markets over the next year.

    The Sandman Intro(TM) CPAP device is a convenient device designed
    for a broad range of patients and provides continuous positive airway
    pressure and heated humidification. According to Andy Ray, Vice
    President and General Manager for Covidien´s Sleep and Oxygen
    Division, "The goal in developing this product was to improve the
    nighttime breathing comfort of patients with obstructive sleep apnea
    (OSA) - which we know to be an increasingly common and serious
    condition - and to accomplish this with a device that is as easy to
    use as it is unobtrusive."

    The Sandman Intro CPAP device is quiet, discreet and user-friendly
    for nightly use at home. At a mere 2.65 pounds, it is also
    lightweight, compact and robust enough for OSA patients who need to
    take their therapy with them when they travel. Travel-friendly
    features include the ability to run on AC/DC or external battery power
    and an altitude compensation feature that automatically adjusts
    pressure up to 9,000 feet of elevation, and compensates for changes in
    barometric pressure to preserve a patient´s prescribed settings.

    Humidification is a popular feature on many CPAP devices. It is
    used to warm and humidify the air delivered by sleep therapy devices
    to reduce upper airway dryness and improve patient comfort. However,
    no other device currently on the market offers integrated heated
    humidification in such a compact manner as the new Sandman Intro CPAP
    device.

    In addition to a water chamber that is easy to clean and refill,
    and the water-resistant housing of the device, the Sandman Intro CPAP
    has a unique "HumidControl" feature. HumidControl works to ensure a
    consistent temperature difference between the water in the chamber and
    ambient air to minimize condensation in the tubing and to keep the
    humidification level constant throughout the night.

    Covidien intends to market the Sandman Intro CPAP device in
    numerous countries where it does business, and added many features
    designed to have global appeal:

    -- Global internal universal power supply and external backup
    battery capability

    -- Unique small product footprint (6.9" x 7.5" x 4.7") and 2.65
    lbs. for light weight portability

    -- Front facing, LCD backlit buttons and display screen to
    improve readability

    -- Rear-routed tubing and a single power cord at the rear for
    less intrusion at the bedside

    -- Built-in patient service and parts replacement reminders

    Covidien has developed a Global Sleep Initiative to unite
    research, diagnosis and therapy resources to improve patient care to
    treat OSA and related sleep disordered breathing conditions. The
    Sandman Intro CPAP device provides a platform for future positive
    airway pressure devices to follow.

    For customers familiar with Covidien´s Sandman(TM) sleep
    diagnostic system that offers market-leading technology and
    innovative, advanced products for recording and scoring sleep studies,
    the Sandman Intro CPAP device represents a welcome addition.

    ABOUT COVIDIEN LTD.

    Covidien is a leading global healthcare products company that
    creates innovative medical solutions for better patient outcomes and
    delivers value through clinical leadership and excellence. Covidien
    manufactures, distributes and services a diverse range of
    industry-leading product lines in four segments: Medical Devices,
    Imaging Solutions, Pharmaceutical Products and Medical Supplies. With
    2007 revenue of nearly $9 billion, Covidien has more than 43,000
    employees worldwide in 57 countries, and its products are sold in over
    130 countries. Please visit www.covidien.com to learn more about our
    business.